VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login to view program details and full enterprise executive list.
DATE
JAN 2021
TABLES
399
PAGES
683
EDITION
16
PRICE
USD $5450

Global market for Cell Surface Markers is expected to reach US$1.1 billion by the year 2027 trailing a post pandemic growth rate of 8.9% for the period 2020 to 2027.Several health systems across the world have begun resuming non-COVID-19 care procedures. Demand is expected to spike in the coming months as delayed care leads to management of more critical cases. The impact of delayed care in oncology is especially expected to be severe with delayed diagnosis and lack of timely treatment likely to increase healthcare costs and mortality. The scenario is expected to create pent-up demand for cancer screening worldwide and spur demand for cell surface markers for cancer stem cells used in diagnostics & drug delivery. Both the United States and the U.K have witnessed over 65% reduction in breast cancer checks during Covid-19. Hospitals the world over will be faced with a huge backlog of cancer screening tests which has been accumulating during the Covid-19 pandemic to be cleared in the coming months. The scenario is a significant setback to the global fight against cancer. Missed diagnosis and delayed surgeries are expected to push up cancer mortality rates significantly over the next few years.
Cell surface markers or cell surface antigens are special carbohydrates or proteins present on cell membrane and can be exploited for identification and classification of cells. While certain proteins participate in transportation of molecules through the membrane, cell surface markers hold a pivotal role in intercellular recognition and communication. These surface markers act exclusive fingerprint of a cell and can be used in a diverse spectrum of applications. Cell surface markers are finding increasing use in research, disease diagnosis, drug discovery, personalized medicine and direct treatment for a specific medical condition. These markers allow researchers to determine cell expression of specific receptors to gain insights into biological response. Cell surface markers are commonly used to evaluate cell proliferation and abnormal cell population along with assessment and quantification of residual diseases. The increasing focus on timely diagnosis for disease prevention and reducing burden on healthcare system is driving the demand for cell surface markers. Over the years, application of cell surface markers has expanded beyond lymphocytes to detection of monocytes, macrophages, progenitor cells, and tumor cells. Cell surface markers exhibit the potential to revolutionize stem cell research. Other exciting areas include personalized medicine wherein analysis and understanding of cells isolated from patients and their response to specific therapy would allow the physician to make safer and effective medical decisions. Further, the introduction of monoclonal antibody producing hybridoma technology is further expanding the application options for cell surface markers. A growing number of healthcare facilities including hospitals, doctor`s offices, and diagnostic centers, as well as research entities including pharmaceutical laboratories, independent research institutions, academic/university research programs, and contract research organizations are prioritizing cell surface markers identification in diagnosis as well as research applications.
An interesting new application area is the growing focus of the researcher community to identify cell surface markers associated with COVID-19 to aid in diagnosis. Researchers have noted variations in immunological state, particularly changes in the normal ratio between CD4 and CD8 ratio in viral infections owing to antiviral immune responses. The normal CD4:CD8 ratio, 2:1, is inverted to less than 1:1 in certain viral infections, which can be used as diagnostic marker. In a recent effort in this direction, researchers used flow cytometry to determine the number of CD4 T and CD8 T cells in blood specimens of COVID-19 patients for finding the CD4:CD8 ratio. Researchers also determined the mean fluorescence intensity (MFI) of cellular markers for identifying their expression. The close resemblance of symptoms of common cold with initial signs of COVID-19 is prompting various hospitals to consider C-reactive protein (CRP) reagents to differentiate the two conditions. CRP is a primary cell marker that can assist physicians in diagnosing and follow-up treatment for the novel coronavirus (2019-nCoV). Patients with fever and a number of other suspected symptoms undergo CRP along with whole blood cell count testing to help clinicians in identifying common cold from COVID-19 infection. Physicians also conduct nucleic acid test and chest imaging to confirm patients with COVID-19. In addition, clinicians monitor CRP and other biochemical markers during the treatment through to patient recovery.
INSIDER ACCESS PRIVILEGES
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of Covid-19 and a Looming Global Recession |
Cell Surface Markers: A Prelude |
Researchers Indentify Over-Expression of CD8 Marker on Cytotoxic T-Cells in Patients with COVID-19 Infection |
Hospitals Eye on CRP as Diagnostic Marker to Distinguish Common Cold from COVID-19 |
Robust Demand for Analytical Techniques and Focus on Timely Diagnosis Drive Growth of Global Cell Surface Markers Market |
Research Dominates Cell Surface Markers Market, Clinical Diagnostics to Exhibit Fastest Growth |
Flow Cytometers Lead the Cell Surface Markers Market |
T and B Cells Dominate the Market |
Developed Regions: Major Revenue Contributors |
Developing Regions Drive Future Growth |
2. FOCUS ON SELECT PLAYERS |
Recent Market Activity |
Innovations & Advancements |
3. MARKET TRENDS & DRIVERS |
High Uptake in Drug Discovery Applications Widens Market Prospects |
Role of Flow Cytometry in Cell Line Development |
Multicolor Flow Cytometry Offers Perfect Option to Understand B-Cell Development |
Hematology Analyzers Gain Traction in Cell Surface Marker Identification |
Growing Hematology Analyzers Market Witnesses Steady Growth |
Key Technology Trends in Hematology Analyzers Market |
Rising Cancer Incidence Worldwide Spurs Demand For Cell Surface Markers |
Select Markers for Cancer Stem Cell Identification |
EXHIBIT 1: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
EXHIBIT 2: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018 |
EXHIBIT 3: Number of New Cancer Cases and Deaths (in Million) by Region for 2018 |
Use of CD Markers in Identification and Classification of Leukocyte Populations |
Most Common CD markers for Flow Cytometry |
Growing Significance of Personalized Medicine: An Opportunity for Cell Surface Markers |
EXHIBIT: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024 |
RNA Sequencing Emerges as Potential Approach to Identify Cell Surface Markers for Enabling Precision Medicine |
Cell Surface Markers Grows Significantly in Stem Cell Research |
Select Cell Surface Markers Used in Stem Cell Identification and Characterization |
Hematopoietic Stem Cell Markers Provide Useful Insights into Hematopoiesis |
Genetically Engineered CAR T-Cells Present Potential Weapon to Eliminate Cancer Stem Cells and Prevent Recurrence of Cancer |
Key Models |
CSC Population & Noteworthy Markers |
ALDH |
CD44 |
CD90 |
CD133 |
EpCAM & EGFR |
Immunotherapy Targets Natural Killer Cells to Offer Hope for Cancer Patients |
Cell Surface Markers Identification Assumes Critical Importance amid Growing Prevalence of Chronic Diseases |
EXHIBIT 10: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others |
EXHIBIT 11: Rising Diabetes Prevalence Presents Opportunity for Cell Surface Markers: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 |
Aging Demographics Present Opportunities for Cell Surface Markers |
EXHIBIT 12: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030 |
Clinical Management of Autoimmune Diseases |
Flow Cytometry Remains the Gold Standard in HIV Testing and Monitoring |
Global HIV Prevalence: 2019 |
Increased Emphasis on Lab Automation Builds Opportunities |
Increasing Investments on Advanced Equipment in Disease Diagnosis Underpin Volume Growth |
Growing Focus on Data Management in Research Programs Extends Opportunities |
Rat Markers |
TABLE: Lineage and Antibodies Specific Rat Markers |
TABLE: Commonly Used Key Rat Markers by Antibodies and Research Area/Target Cell |
New Anti-Rat Antibodies Products Expand Scope of Applications |
TABLE: ED Clone Anti-Rat Antibodies by Marker and Cell Type |
TABLE: Rat Flow Cytometry Panels |
4. GLOBAL MARKET PERSPECTIVE |
World Current & Future Analysis for Cell Surface Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Cell Surface Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Cell Surface Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for PCR Arrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for PCR Arrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for PCR Arrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for T Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for T Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for T Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for B Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for B Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for B Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for NK Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for NK Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for NK Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Monocyte Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Monocyte Cell by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Monocyte Cell by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other Cell Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Other Cell Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Other Cell Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Hospitals & Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Hospitals & Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Hospitals & Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
USA Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
USA Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
USA 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
USA Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
USA 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
USA Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
USA 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
USA Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
USA 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
Largest Market for Cell Surface Markers |
Rising Cancer Cases Spur Growth in Cell Surface Markers Market |
Estimated Number of New Cancer Cases and Deaths in the US (2019) |
Number of Cancer Drugs in Development for the Years 2006, 2009, 2012, 2015 and 2018 |
Market Benefits from Growing Funding for Stem Cell Research |
EXHIBIT 14: Stem Cell Research Funding in the US (in US$ Million) for the Years 2011 through 2017 |
CANADA |
Canada Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Canada Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Canada 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Canada Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Canada 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Canada Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Canada 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Canada Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Canada 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
High Focus on Improving Healthcare Augurs Well for Market Growth |
Number of New Cancer Cases in Canada: 2019 |
JAPAN |
Japan Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Japan Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Japan 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Japan Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Japan 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Japan Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Japan 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Japan Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Japan 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
CHINA |
China Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
China Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
China 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
China Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
China 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
China Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
China 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
China Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
China 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
Increasing Cancer Research to Drive Cell Surface Markers Market |
Number of New Cancer Cases Diagnosed (in Thousands) in China: 2018 |
EUROPE |
Market Facts & Figures |
European Cell Surface Markers Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
Antibodies (Product) Market Share (in %) by Company in Europe: 2019 & 2025 |
PCR Arrays (Product) Market Share (in %) of Major Players in Europe: 2019 & 2025 |
T Cell Surface Markers (Cell Type) Competitor Market Share Analysis (in %) in Europe: 2019 & 2025 |
B Cell Surface Markers (Cell Type) Market in Europe: Competitor Revenue Share Shift (in %) for 2019 & 2025 |
NK Cell Surface Markers (Cell Type) Competitor Market Share (in %) Positioning in Europe for 2019 & 2025 |
Monocyte Cell Surface Markers (Cell Type) Key Player Market Share Breakdown (in %) in Europe: 2019 & 2025 |
Europe Current & Future Analysis for Cell Surface Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
Europe Historic Review for Cell Surface Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Europe 15-Year Perspective for Cell Surface Markers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Europe Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Europe 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Europe Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Europe 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Europe Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Europe 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Europe Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Europe 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
Cancer Incidence in Europe: Number of New Cancer Cases (in Thousands) by Site for 2018 |
FRANCE |
France Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
France Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
France 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
France Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
France 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
France Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
France 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
France Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
France 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
GERMANY |
Germany Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Germany Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Germany 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Germany Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Germany 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Germany Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Germany 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Germany Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Germany 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
ITALY |
Italy Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Italy Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Italy 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Italy Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Italy 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Italy Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Italy 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Italy Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Italy 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
UNITED KINGDOM |
UK Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UK Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UK 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UK Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UK 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UK Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UK 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UK Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UK 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
SPAIN |
Spain Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Spain Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Spain 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Spain Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Spain Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Spain 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Spain Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Spain Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Spain 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Spain Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Spain Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Spain 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
RUSSIA |
Russia Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Russia Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Russia 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Russia Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Russia Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Russia 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Russia Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Russia Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Russia 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Russia Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Russia Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Russia 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF EUROPE |
Rest of Europe Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Europe Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Europe 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Europe Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Europe 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Europe Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Europe 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Europe Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Europe 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
ASIA-PACIFIC |
Asia-Pacific Current & Future Analysis for Cell Surface Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
Asia-Pacific Historic Review for Cell Surface Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Asia-Pacific 15-Year Perspective for Cell Surface Markers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Asia-Pacific Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Asia-Pacific 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Asia-Pacific Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Asia-Pacific 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Asia-Pacific Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Asia-Pacific 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Asia-Pacific Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Asia-Pacific 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
Increased Cancer Research to Drive the Market for Cell Surface Markers |
Cancer Incidence in Asia: Number of New Cancer Cases (in Thousands) for 2019 |
AUSTRALIA |
Australia Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Australia Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Australia 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Australia Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Australia Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Australia 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Australia Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Australia Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Australia 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Australia Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Australia Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Australia 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
INDIA |
India Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
India Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
India 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
India Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
India Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
India 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
India Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
India Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
India 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
India Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
India Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
India 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
India Eyes on RT-LAMP Kits to Ramp up COVID-19 Testing Capacity |
Molecular Diagnostic Market in India to Witness Significant Growth |
Growth Drivers in a Nut Shell |
SOUTH KOREA |
South Korea Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
South Korea Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
South Korea 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
South Korea Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
South Korea Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
South Korea 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
South Korea Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
South Korea Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
South Korea 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
South Korea Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
South Korea Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
South Korea 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Asia-Pacific Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Asia-Pacific 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Rest of Asia-Pacific Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Asia-Pacific Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Asia-Pacific 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Rest of Asia-Pacific Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Asia-Pacific Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Asia-Pacific 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Rest of Asia-Pacific Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Asia-Pacific Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Asia-Pacific 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
LATIN AMERICA |
Latin America Current & Future Analysis for Cell Surface Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
Latin America Historic Review for Cell Surface Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Latin America 15-Year Perspective for Cell Surface Markers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
Latin America Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Latin America Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Latin America 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Latin America Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Latin America Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Latin America 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Latin America Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Latin America Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Latin America 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Latin America Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Latin America Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Latin America 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
ARGENTINA |
Argentina Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Argentina Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Argentina 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Argentina Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Argentina Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Argentina 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Argentina Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Argentina Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Argentina 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Argentina Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Argentina Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Argentina 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
BRAZIL |
Brazil Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Brazil Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Brazil 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Brazil Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Brazil Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Brazil 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Brazil Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Brazil Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Brazil 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Brazil Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Brazil Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Brazil 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
MEXICO |
Mexico Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Mexico Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Mexico 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Mexico Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Mexico Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Mexico 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Mexico Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Mexico Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Mexico 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Mexico Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Mexico Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Mexico 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF LATIN AMERICA |
Rest of Latin America Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Latin America Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Latin America 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Rest of Latin America Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Latin America Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Latin America 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Rest of Latin America Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Latin America Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Latin America 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Rest of Latin America Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Latin America Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Latin America 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
MIDDLE EAST |
Middle East Current & Future Analysis for Cell Surface Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 |
Middle East Historic Review for Cell Surface Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Middle East 15-Year Perspective for Cell Surface Markers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
Middle East Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Middle East Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Middle East 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Middle East Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Middle East Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Middle East 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Middle East Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Middle East Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Middle East 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Middle East Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Middle East Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Middle East 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
IRAN |
Iran Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Iran Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Iran 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Iran Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Iran Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Iran 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Iran Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Iran Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Iran 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Iran Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Iran Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Iran 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
ISRAEL |
Israel Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Israel Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Israel 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Israel Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Israel Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Israel 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Israel Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Israel Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Israel 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Israel Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Israel Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Israel 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
SAUDI ARABIA |
Saudi Arabia Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Saudi Arabia Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Saudi Arabia 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Saudi Arabia Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Saudi Arabia Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Saudi Arabia 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Saudi Arabia Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Saudi Arabia Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Saudi Arabia 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Saudi Arabia Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Saudi Arabia Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Saudi Arabia 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
UNITED ARAB EMIRATES |
UAE Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UAE Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UAE 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
UAE Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UAE Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UAE 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
UAE Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UAE Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UAE 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
UAE Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
UAE Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
UAE 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF MIDDLE EAST |
Rest of Middle East Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Middle East Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Middle East 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Rest of Middle East Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Middle East Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Middle East 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Rest of Middle East Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Middle East Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Middle East 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Rest of Middle East Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Rest of Middle East Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Rest of Middle East 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
AFRICA |
Africa Current & Future Analysis for Cell Surface Markers by Product - Antibodies and PCR Arrays - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Africa Historic Review for Cell Surface Markers by Product - Antibodies and PCR Arrays Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Africa 15-Year Perspective for Cell Surface Markers by Product - Percentage Breakdown of Value Sales for Antibodies and PCR Arrays for the Years 2012, 2020 & 2027 |
Africa Current & Future Analysis for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Africa Historic Review for Cell Surface Markers by Cell Type - T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Africa 15-Year Perspective for Cell Surface Markers by Cell Type - Percentage Breakdown of Value Sales for T Cell, B Cell, NK Cell, Monocyte Cell and Other Cell Types for the Years 2012, 2020 & 2027 |
Africa Current & Future Analysis for Cell Surface Markers by Application - Research and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Africa Historic Review for Cell Surface Markers by Application - Research and Clinical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Africa 15-Year Perspective for Cell Surface Markers by Application - Percentage Breakdown of Value Sales for Research and Clinical for the Years 2012, 2020 & 2027 |
Africa Current & Future Analysis for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 |
Africa Historic Review for Cell Surface Markers by End-Use - Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 |
Africa 15-Year Perspective for Cell Surface Markers by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Hospitals & Clinical Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
IV. COMPETITION |
Total Companies Profiled : 70 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com